IA
CLBT icon

Investor AB’s Cellebrite CLBT Stock Holding History

Investor AB’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$758K Buy
+55,000
New +$829K 0.01% 4
2025
Q4 		– Sell
-40,000
Closed -$741K – 13
2025
Q3 		$741K Hold
40,000
– – 0.01% 6
2025
Q2 		$640K Buy
40,000
+5,000
+14% +$89.1K 0.01% 7
2025
Q1 		$680K Sell
35,000
-5,000
-13% -$105K 0.02% 7
2024
Q4 		$881K Buy
+40,000
New +$770K 0.02% 4

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Investor AB's CLBT Position: Q1 2026 in Review

Investor AB opened a new position in Cellebrite (CLBT) in Q1 2026: 55,000 shares worth $758K. The stake represents 0.01% of the portfolio and ranks #4 among its holdings. This is a return to the name: Investor AB previously reported a position in CLBT as recently as Q3 2025.

Investor AB first reported a position in CLBT in Q4 2024 and has held it in 5 quarters since. The position peaked at $881K in Q4 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Investor AB held 55,000 shares of Cellebrite worth $758K as of Q1 2026.
  • Cellebrite was a new Investor AB position in Q1 2026.
  • Cellebrite made up 0.01% of Investor AB's portfolio in Q1 2026, its #4 holding.
  • Investor AB first reported a position in Cellebrite in Q4 2024 and has held it in 5 quarters since.
  • Investor AB's Cellebrite position peaked at $881K in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Investor AB's 13F filing for Q1 2026, filed 15 May 2026.